Scan Smarter. Trade What Works.
Looking to sell premium without getting run over? The best bull put spreads start with stocks trending cleanly higher, not coasting sideways or sitting on an earnings bomb. I built a ThinkorSwim (TOS) scanner to surface those setups—no noise, no guesswork.
Want to see which names made the list and the scan criteria (who else is showing you their exact scans they use)?
Your Weekly Income Report
We closed nine profitable trades and one loser across our services last week, netting nearly $1,300 in cash in the live account. This included three more Millionaire’s Trading Club positions, putting us 40% of the way to our $2,500 income goal.
We also exited another Russell 2000 bear call spread in the 5K Challenge program, earning an 11.4% return in a mere 22 hours. This week, we’ll take a closer look at why we gravitate toward trading this index in our quest for short-term income generation.
Your Weekly Income Report
We picked up the pace a bit during the holiday-shortened week, closing five trades. Although we were net negative due to a loss in the 5K Challenge program, our four winners totaled about $1,460 in cash.
Among last week’s profitable trades was a pre-earnings play on Netflix (NFLX) and a diagonal call spread on a popular gold ETF that generated $910 in profits.
Gold has been one of our go-to sectors this year, for obvious reasons. In fact, we’ve racked up more than $4,000 in cash trading gold-related equities year to date.
Straddle Strategy Shines With Volatile TSLA
Despite our initial challenges with a Tesla (TSLA) credit spread position, we managed to greatly reduce our loss on the recovery trade. When we went back to the stock this month in the Income Masters program, we tried a new strategy that paid off quickly, yielding a nearly 15% return in just three days. Plus, we generated more than enough cash to offset our loss on the previous position.
Find out how we did it.
1 Stock, 20 Winners, $5,732 in Cash
Income Masters members pocketed over $3,100 in cash last week, closing out nine profitable trades. The largest income generator was a recovery trade on a drugmaker we’ve been trading successfully for the past year.
In fact, last week’s closeout represented the 20th winning trade on the stock in a row with more than $5,700 in total cash generated. And we plan to go back to it with another trade this week when we kick off Income Madness.
How We’ve Been Cashing In On The GLP-1 Craze
The booming market for weight-loss drugs, particularly GLP-1 agonists, have led to substantial gains in drugmakers Novo Nordisk (NVO) and Eli Lilly (LLY). The latter is seeing its share price approach the $1,000 level, putting it out of reach for most investors.
But we’ve been able to generate thousands of dollars from LLY over the past year and boost our rates of return using a simple options-selling strategy.
Market Ignores Hawkish Fed, Cheers CPI
The Fed rate frenzy is almost getting as hyped as seeing Roaring Kitty return to trading GME after years of being silent. All investors watched as the Consumer Price Index (CPI) numbers signaled ongoing disinflation. While stocks shot higher on Wednesday, investors ignored the Fed presentation later in the day. That was a mistake as the Fed laid out a troubling scenario.
Let’s start with the good news. Consumer Prices are rising less than the consensus range. For example, the year-over-year number was expected to increase by 3.4%, whereas the actual CPI number came in at 3.3%.
Is It Time To Get Into Value Investing Again?
Mega-cap tech stocks continue to dominate the market, but beneath their success lies a growing unease among investors about the Federal Reserve’s interest rate policies. While these tech giants boast substantial cash reserves and can withstand a “higher for longer” strategy, the average S&P 500 stock is more vulnerable than ever to rising yields. Although the S&P 500 is up for the year, not all companies are sharing in the glory.
The Coiled Spring Is Ready To Pop
The next few days are crucial for the markets, and your portfolios. The market wants to see a rate cut over the summer, but I don’t think they’ll get what they want, and that could lead to a bumpy ride ahead. Let’s break down what you need to know.
OIW Members Bank 3 Back-to-Back Winners
We’re using bullish investor sentiment and the buzz surrounding popular weight-loss drugs to earn outsized returns on the biggest beneficiaries of the trend.
